Dr. Chiara Fiorentini received her Medical degree at University of Brescia in 1998, where she had then her Ph.D in Neuroscience (2003). From 2005, she is Assistant Professor of Pharmacology at the Department of Molecular and Translational Medicine, University of Brescia. She is currently involved in the study of the biological and molecular mechanisms regulating the activity of the dopaminergic system and transduction mechanisms associated with dopamine receptors. Her main scientific activity has been focused on the mechanisms regulating dopamine receptor heterodimerization and the role of these heterodimers in the pathogenesis of Parkinsonís disease and L-DOPA-induced dyskinesia. Recently, she has been involved in the development of human induced pluripotent stem cells (hiPSC) technology as a novel tool for investigating the dopaminergic system both in physiological and pathological conditions. She is author of multiple articles in peer-reviewed journals.
Dr. Fiorentiniís research is focused on the study of the biological and molecular mechanisms regulating the activity of the dopaminergic system in both physiological and pathological conditions, including Parkinsonís disease and its complications, depression and schizophrenia.